PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
06-Feb-2024 INSERTING and REPLACING GE HealthCare Reports Fourth Quarter and Full Year 2023 Financial Results Businesswire
06-Feb-2024 SpineGuard Reaches the Milestone of 100,000 Surgeries and Over 30 Publications With DSG® Technology Businesswire
06-Feb-2024 Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering Businesswire
06-Feb-2024 Experienced Life Sciences Leader Joins IPS as Regional Director to Lead New Australian Office Businesswire
06-Feb-2024 AstraZeneca expands US manufacturing footprint to accelerate ambitions in next-generation cell therapy discovery and development Businesswire
06-Feb-2024 CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug Businesswire
06-Feb-2024 SierraConstellation Partners Receives Industry Recognition for Work with Tricida Businesswire
06-Feb-2024 Aro Biotherapeutics to Present Updates on ABX1100, a CD71 Centyrin – Gys1 siRNA Conjugate for the Treatment of Pompe Disease at the 20th Annual WORLD Symposium 2024​ Meeting Businesswire
06-Feb-2024 IQVIA Named to Fortune® World's Most Admired Companies™ List, Ranked #1 in Its Sector for the Third Consecutive Year Businesswire
06-Feb-2024 Simulations Plus to Participate in Upcoming Healthcare Conferences Businesswire
06-Feb-2024 2 Day Arab Pharmacovigilance Guideline Practical Requirements Training Course (ONLINE EVENT: June 13-14, 2024) - ResearchAndMarkets.com Businesswire
06-Feb-2024 Agile Leadership for Pharma and Biopharma Professionals in a Hybrid World Training Course (Online Event) - ResearchAndMarkets.com Businesswire
06-Feb-2024 Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice Businesswire
06-Feb-2024 Immunome to Acquire AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals Businesswire
06-Feb-2024 Rallybio Announces Portfolio Prioritization and Provides Corporate Update Businesswire
06-Feb-2024 AI and Automation Ignite a Transformative Year in Procurement, Keelvar Study Reveals Businesswire
06-Feb-2024 Global Testing Laboratories Strategic Business Report 2024 - ResearchAndMarkets.com Businesswire
06-Feb-2024 Encoded Therapeutics Announces US IND Clearance and Australian CTA Approval for Dravet Syndrome Gene Therapy Candidate ETX101 Businesswire
06-Feb-2024 New T-FINDER Platform Provides Deep Insights Into T Cell Responses Against Novel Cancer Vaccine Newswire
06-Feb-2024 Septerna Appoints Industry Veterans Bernard Coulie, M.D., Ph.D., and Shalini Sharp to its Board of Directors Businesswire